136 related articles for article (PubMed ID: 2785015)
1. Clinical application of SPECT in adrenal imaging with iodine-131 6 beta-iodomethyl-19-norcholesterol.
Ishimura J; Kawanaka M; Fukuchi M
Clin Nucl Med; 1989 Apr; 14(4):278-81. PubMed ID: 2785015
[TBL] [Abstract][Full Text] [Related]
2. [Scintigraphic exploration of the adrenal glands using I-131-6 beta iodomethyl-19-norcholesterol. A practical guide].
Kraimps JL; Bardet S; Nocaudie-Calzada M; Tabarin A; Wémeau JL
Ann Chir; 1999; 53(3):255-60. PubMed ID: 10339872
[No Abstract] [Full Text] [Related]
3. The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome.
Valk TW; Gross MD; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH
J Nucl Med; 1980 Nov; 21(11):1069-72. PubMed ID: 7431105
[TBL] [Abstract][Full Text] [Related]
4. Adrenocortical SPECT using iodine-131 NP-59.
Hwang I; Balingit AG; Georgitis WJ; Sisson JC; Shapiro B
J Nucl Med; 1998 Aug; 39(8):1460-3. PubMed ID: 9708530
[TBL] [Abstract][Full Text] [Related]
5. Failure to visualize adrenal glands in a patient with bilateral adrenal hyperplasia.
Gordon L; Mayfield RK; Levine JH; Lopes-Virella MF; Sagel J; Buse MG
J Nucl Med; 1980 Jan; 21(1):49-51. PubMed ID: 7356739
[TBL] [Abstract][Full Text] [Related]
6. [Clinical values of adrenal scintigraphy by I-6-beta-iodomethyl-19-norcholesterol (123I-NCL) (author's transl)].
Tateno Y; Shishido F; Kamoi I; Matsuura K; Takagi Y; Hashimoto S; Hotta T; Arimizu N; Fukushi K; Irie T; Ido T; Kojima M; Maeda M; Ogawa H; Itoh T
Kaku Igaku; 1982 Mar; 19(2):245-53. PubMed ID: 7109324
[No Abstract] [Full Text] [Related]
7. Primary adrenocortical nodular dysplasia presented as adrenal adenoma by functional scintigraphy.
García-Mayor RV; Pérez Mendez L; Páramo C; Andrade A; Guitian R; Butron M
Clin Nucl Med; 1993 Mar; 18(3):220-2. PubMed ID: 8462213
[TBL] [Abstract][Full Text] [Related]
8. Adrenal gland imaging with multiplane tomography.
Wahner HW; Hammell TC
Clin Nucl Med; 1979 Apr; 4(4):152-7. PubMed ID: 477144
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol (NP-59) imaging.
Kazerooni EA; Sisson JC; Shapiro B; Gross MD; Driedger A; Hurwitz GA; Mattar AG; Petry NA
J Nucl Med; 1990 Apr; 31(4):526-34. PubMed ID: 2324830
[TBL] [Abstract][Full Text] [Related]
10. Adrenal imaging with 131I-adosterol (NCL-6-131I) by diverging and pinhole methods. II. Analysis of abnormal adrenal images.
Nakajo M
Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Feb; 42(2):160-87. PubMed ID: 7110924
[No Abstract] [Full Text] [Related]
11. Scintigraphic studies in adrenal hypertension.
Gross MD; Shapiro B
Semin Nucl Med; 1989 Apr; 19(2):122-43. PubMed ID: 2652311
[TBL] [Abstract][Full Text] [Related]
12. Adrenal scintiscanning with NP-59, a new radioiodinated cholesterol agent.
Miles JM; Wahner HW; Carpenter PC; Salassa RM; Northcutt RC
Mayo Clin Proc; 1979 May; 54(5):321-7. PubMed ID: 431134
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of adrenal imaging with 123I-labeled-6 beta-iodomethyl-19-norcholesterol (author's transl)].
Shishido F; Tateno Y; Ido T; Irie T; Suzuki K; Fukushi K; Iwata R; Kojima M; Maeda M; Ito T; Ogawa H
Radioisotopes; 1980 Nov; 29(11):526-32. PubMed ID: 7244299
[TBL] [Abstract][Full Text] [Related]
14. Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism.
Gordon L; Levine JH; Mayfield RK; Buse MG
J Nucl Med; 1979 Aug; 20(8):897-8. PubMed ID: 541739
[No Abstract] [Full Text] [Related]
15. Clinical significance of the solitary functioning adrenal gland.
Gross MD; Shapiro B; Freitas JE; Meyers L; Francis I; Thompson NW; Wortsman J
J Nucl Med; 1991 Oct; 32(10):1882-7. PubMed ID: 1919725
[TBL] [Abstract][Full Text] [Related]
16. Hormonal, Radiological, NP-59 Scintigraphy, and Pathological Correlations in Patients With Cushing's Syndrome Due to Primary Pigmented Nodular Adrenocortical Disease (PPNAD).
Vezzosi D; Tenenbaum F; Cazabat L; Tissier F; Bienvenu M; Carrasco CA; Laloi-Michelin M; Barrande G; Lefebvre H; Hiéronimus S; Tabarin A; Bertagna X; Legmann P; Vantyghem MC; Bertherat J
J Clin Endocrinol Metab; 2015 Nov; 100(11):4332-8. PubMed ID: 26390100
[TBL] [Abstract][Full Text] [Related]
17. Application of adrenal maximum standardized uptake value to
Nakajo M; Jinguji M; Tani A; Yoshiura T
Eur J Radiol; 2020 Dec; 133():109397. PubMed ID: 33190101
[TBL] [Abstract][Full Text] [Related]
18. [Adrenocortical scintigraphy to evaluate incidental adrenal mass (incidentaloma) discovered on computed tomography].
Tsukamoto E; Itoh K; Furudate M
Kaku Igaku; 1991 Jun; 28(6):629-34. PubMed ID: 1895559
[TBL] [Abstract][Full Text] [Related]
19. Positive iodine-131 6 beta-iodomethyl-19-norcholesterol (NP-59) adrenal images can precede return of adrenocortical function after o,p' DDD treatment.
Sparagana M; Ackerman L
Clin Nucl Med; 1988 May; 13(5):348-51. PubMed ID: 3390980
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of a new adrenal scanning agent, 6-methyl-75Se-selenomethyl-19-norcholest-5 (10)-en-3 beta-ol (75Se-Scintadren) and 6 beta-iodomethyl-19-norcholest-5 (10)-en-3 beta-ol (131I-Adosterol) (author's transl)].
Seto H; Futatsuya R; Mori H; Koizumi K; Hisada K
Kaku Igaku; 1979 Apr; 16(2):183-9. PubMed ID: 470240
[No Abstract] [Full Text] [Related]
[Next] [New Search]
